There is no evidence-based session count that fits everyone. In one 2026 prospective study, all 39 participants received two XERF sessions four weeks apart; outcomes were checked 30 and 90 days after the last visit. A separate retrospective study followed 16 people after one session through three months. Neither establishes how many sessions you personally need or how long an effect lasts.
What timelines have researchers actually observed?
The best starting point is to separate a study schedule from a treatment promise. The prospective four-site XERF study enrolled 39 people with facial laxity. Each completed two sessions, four weeks apart. Investigators scored clinical photographs 30 and 90 days after the final session. They reported short-term improvement, but the paper did not test whether one session would have been enough, how long the effect would persist beyond 90 days, or how XERF compares with no treatment.
The 16-person retrospective study examined a single session, with information gathered immediately afterward and at one and three months. It reported changes in facial measurements and skin-quality scores. Its small size, all-female completed sample, and lack of a control group limit what it can predict for a new patient.
Studied retrospectively in 16 people. Follow-up extended to three months; the design cannot determine a reliable personal response rate.
Studied prospectively in 39 people. Sessions were four weeks apart; 30- and 90-day assessments followed the second treatment.
No XERF-specific durability estimate is established by those short follow-up periods. Ask how a provider plans to track and reassess your result.
Why does a provider’s plan sometimes differ from a paper?
A study protocol holds timing and treatment areas relatively steady so results can be interpreted. A real consultation begins with a face, health history, goal, and tolerance that may not match the study population. Treatment area and settings can vary. That is a reason to ask for a written plan, not a reason to accept an unexplained package.
The American Academy of Dermatology describes noninvasive radiofrequency tightening as often gradual and modest. Its general guidance is about the category, not a XERF-specific timetable. It should not be converted into “everyone sees X by week Y.”
How can you tell whether anything changed?
Before treatment, identify one or two concrete observations: for example, how the skin along a jawline looks in the same relaxed pose, or whether a crease changes in consistent lighting. Ask for photographs from the same camera angle, distance, expression, and light. Compare them at a planned follow-up after swelling has settled. A flattering selfie taken in different light can manufacture an apparent result.
Also decide what would make you stop. If your main concern turns out to be volume loss, pigmentation, or substantial laxity, repeating the same energy treatment may not answer it. Ask the clinician what alternatives they would discuss and when a different assessment is appropriate.
Questions before buying a series
- What is the reason for the proposed number and spacing of visits?
- What change would count as enough to continue, and at which follow-up?
- What is the full price for the proposed plan and what is included?
- What happens if a session is delayed or the skin reacts unexpectedly?
There is no published price on this site because none was verified. XERF inquiries for visitors from the existing service area go through Detroit Beauty Connect for a Garden City appointment. Book a free consultation
Sources and how to read them
We distinguish device descriptions, regulatory records, human clinical reports, and research on radiofrequency as a category. Findings in a small study or another device should not be treated as a prediction for one XERF patient.
- Weiss et al., prospective XERF study, 2026
- Erlich et al., retrospective XERF study, 2026
- American Academy of Dermatology, skin tightening guidance
- Cynosure Lutronic, XERF product information
Researched by Detroit Beauty Connect, September 27, 2026. Informational only; this page is not a diagnosis, a treatment plan, or a claim of clinician review. Ask the treating professional for advice specific to you.